Sensory re-education pilot program following chemotherapy-induced peripheral neuropathy in cancer patients

Johanne Hébert, Anne-Sophie Bergeron, Christine Claveau

Abstract


A pilot program for sensory re-education following chemotherapy-
induced peripheral neuropathy (CIPN) has been developed by an occupational therapist working in a cancer treatment centre in Quebec. Inspired by the somatosensory pain rehabilitation (SPR) method developed by Spicher (2003) for nerve injuries, this is an innovative program in oncology for patients with neuropathy-related pain or discomfort in their hands or feet. The program includes a sensory re-education component and a physical exercise component. It aims to reduce the symptoms of neuropathy and improve functional capacity and quality of life. The results are promising in patients who enrol in the program shortly after the onset of symptoms of CIPN, who actively commit to the program and who are diligent in adhering to the recommendations. Additional studies will be necessary, however, to demonstrate further and validate the benefits of a program of this nature for CIPN patients.


Full Text:

PDF

References


Banach, M., Juranek, J. K., & Zygulska, A. L. (2016). Chemotherapy-induced neuropathies–A growing problem for patients and health care providers. Brain and Behavior, 7(1), e00558. https://doi.org/10.1002/brb3.558

Bao, T., Basal, C., Seluzicki, C., Li, S. Q., Seidman, A. D., & Mao, J.J. (2016). Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: Prevalence, risk factors, and fall risk. Breast Cancer Research and Treatment, 159(2), 327–333. https://doi.org/10.1007/s10549-016-3939-0

Beijers, A. J. M., Mols, F., & Vreugdenhil, G. (2014). A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration. Support Care Cancer, 22(7), 1999–2007. https://doi.org/10.1007/s00520-014-2242-z

Bennett, M. I., Kaasa, S., Barke, A., Korwisi, B., Rief, W., & Treede, R.D. (2019). The IASP classification of chronic pain for ICD-11: Chronic cancer-related pain. Pain, 160(1), 38–44. https://doi.org/10.1097/j.pain.0000000000001363

Bennett, M. I., Rayment, C., Hjermstad, M., Aass, N., Caraceni, A., & Kaasa, S. (2012). Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review. Pain, 153(2), 359–365. https://doi.org/10.1016/j.pain.2011.10.028

Bland, K. A., Kirkham, A. A., Bovard, J., Shenkier, T., Zucker, D., McKenzie, D. C., Davis, M. K., Gelmon, K.A., & Campbell, K. L. (2019). Effect of exercise on Taxane chemotherapy-induced peripheral neuropathy in women with breast cancer: A randomized controlled trial. Clinical Breast Cancer, 19(6), 411–422. https://doi.org/10.1016/j.clbc.2019.05.013

Boureau, F., Luu, M., Doubrere, J. F., & Gay, C. (1984). Élaboration d’un questionnaire d’auto-évaluation de la douleur par liste de qualificatifs: Comparaison avec le McGill pain questionnaire de Melzack. Thérapie, 39(2), 119–129.

Brand, T., Pischke, C. R., Steenbock, B., Schoenbach, J., Poettgen, S., Samkange-Zeeb, F., & Zeeb. H. (2014). What works in community-based interventions promoting physical activity and healthy eating? A review of reviews. International Journal of Environmental Research and Public Health. 11(6), 5866–5888. https://doi.org/10.3390/ijerph110605866

Buffart, L. M., Galvao, D. A., Brug, J., Chinapaw, M. J. M. et Newton, R. U. (2014). Evidence-based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions. Cancer Treatment Reviews, 40(2), 327–340. https://doi.org/10.1016.j.ctrv.2013.06.007

Cavalli, E., Mammana, S., Nicoletti, F., Bramanti, P., & Mazzon, E. (2019). The neuropathic pain: An overview of the current treatment and future therapeutic approaches. International Journal of Immunopathology and Pharmacology, 33, 2058738419838383. https://doi.org/10.1177/2058738419838383

Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., Finnerup, N. B., Eccleston, C., Kalso, E., Bennett, D. L., & Raja, S. N. (2017). Neuropathic pain. Nature Reviews Disease Primers 16(3), 17002. https://doi.org/10.1038/nrdp.2017.2

Cooper, M. A., Kluding, P. M., & Wright, D. E. (2016). Emerging relationships between exercise, sensory nerves, and neuropathic pain. Front and Neuroscience, 10, 372. https://doi.org/10.3389/fnins.2016.00372

Cramp, F., & Byron-Daniel, J. (2012). Exercise for the management of cancer-related fatigue in adults. Cochrane Database Systematic Reviews, 11(11), CD006145. https://doi.org/10.1002/14651858.CD006145.pub3

Dhawan, S., Andrews, R., Kumar, L., Wadhwa, S., & Shukla, G. (2020). A randomized controlled trial to assess the effectiveness of muscle strengthening and balancing exercises on chemotherapy-induced peripheral neuropathic pain and quality of life among cancer patients. Cancer Nursing, 43(4), 269–280. https://doi.org/10.1097/NCC.0000000000000693

Djuric, Z., Ellsworth, J. S., Weldon, A. L., Ren, J., Richardson, C. R., Resnicow, K., Newman, L., Hayes, D. F., & Sen, A. (2011). A diet and exercise intervention during chemotherapy for breast cancer. The Open Obesity Journal, 3, 87–97. https://doi.org/10.2174/1876823701103010087

Edwards, H. L., Mulvey, R. M., & Bennett, M. I. (2019). Cancer-related neuropathic pain. Cancer, 11(3), 373. https://doi.org/10.3390/cancers11030373

Fernandez, S., Franklin, J., Amlani, N., DeMilleVille, C., Lawson, D., & Smith, J. (2015). Physical activity and cancer: A cross-sectional study on the barriers and facilitators to exercise during cancer treatment. Canadian Oncology Nursing Journal, 25(1), 37–48. https://doi.org/10.5737/236880762513742

Garcia, D. O., & Thomson, C.A. (2014). Physical activity and cancer survivorship. Nutrition in Clinical Practice, 29(6), 768–779. https://doi.org/10.1177/0884533614551969

Hammond, E. A., Pitz, M., & Shay, B. (2019). Neuropathic pain in taxane-induced peripheral neuropathy: Evidence for exercise in treatment. Neurorehabilitation and Neural Repair, 33(10), 792–799. https://doi.org/10.1177/1545968319860486

Hawkes, A. L., Chambers, S. K., Pakenham, K. I., Patrao, T. A., Baade, P. D., Lynch, B. M., Aitken, J. F., Meng, X., & Courneya, K. S. (2013). Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: A randomized controlled trial. Journal of Clinical Oncology, 31(18), 2313–2321. https://doi.org/10.1200/JCO.2012.45.5873

Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., Chauhan, C., Gavin, P., Lavino, A., Lustberg, M., Paice, J., Schneider, B., Smith, M., Smith, T., Terstriep, S., Wagner Johnston, N., Bak, K., & Loprinzi, C. (2014). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of clinical oncology, 32(18), 1941–1967. https://doi.org/10.1200/JCO.2013.54.0914

Hong, J. S., Tian, J., & Wu, L. H. (2014). The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients. Current Oncology, 21(4), 174–180. https://doi.org/10.3747/co.21.1984

Huemer, M., Jahn-Kuch, D., Hofmann, G., & Pichler, M. (2022). A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain. Complementary Therapies in Clinic Practice, 48, 101599. https://www.sciencedirect.com/science/article/pii/S1744388122000676?via%3Dihub

Jensen, T. S., Baron, R., Haanpää, M., Kalso, E., Loeser, J. D., Rice, A. S., & Treede, R. D. (2011). A new definition of neuropathic pain. Pain, 152(10), 2204–2205. https://doi.org/0.1016/j.pain.2011.06.017

Jones, R. C. W, Lawson, E., & Backonja, M. (2016). Managing neuropathic pain. The Medical Clinic of North America, 100(1), 151–167. https://doi.org/10.1016/j.mcna.2015.08.009

Kerckhove, N., Collin, A., Condé, S., Chaleteix, C., Pezet, D., & Balayssac, D. (2017). Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: A comprehensive literature review. Frontiers in Pharmacology, 8, 86. https://doi.org/10.3389/fphar.2017.00086

Kleckner, I. R., Kamen, C., Gewandter, J. S., Mohile, N. A., Heckler, C. E., Culakova, E., Fung, C., Janelsins, M. C., Asare, M., Lin, P. J., Reddy, P. S., Giguere, J., Berenberg, J., Kesler, S. R., & Mustian, K. M. (2018). Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: A multicenter, randomized controlled trial. Support Care Cancer, 26(4), 1019–1028. https://doi.org/10.1007/s00520-017-4013-0

Kneis, S., Wehrle, A., Muller, J., Maurer, C., Gollhofer, A., & Bertz, H. (2019). It’s never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: Results of a randomized controlled trial. BMC Cancer, 19(1), 414. https://doi.org/10.1186/s12885-019-5522-7

Knoerl, R., Chornoby, Z., & Smith, E. M. L. (2018). Corrigendum to ‘estimating the frequency, severity, and clustering of SPADE symptoms in chronic painful chemotherapyinduced peripheral neuropathy. Pain Management Nursing, 19(4), 354–365. https://doi.org/10.1016/j.pmn.2018.01.001

Knoerl, R., Gilchrist, L., Kanzawa-Lee, G., Donohoe, C., Bridges, C., & Lavoie Smith, E. M. (2020). Proactive rehabilitation for chemotherapy-induced peripheral neuropathy. Seminars in Oncology Nursing, 36(1), 150983. https://doi.org/10.1016/j.soncn.2019.150983

Kolb, N. A., Smith, A. G., Singleton, J. R., Beck, S. L., Stoddard, G. J., Brown, S., & Mooney, K. (2016). The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurology, 73(7), 860–866. https://doi.org/10.1001/jamaneurol.2016.0383

Mold, J. W., Vesely, S. K., Keyl, B. A., Schenk, J. B., & Roberts, M. (2004). The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. Journal of the American Board of Family Practice. 17(5), 309–318. https://doi.org/10.3122/jabfm.17.5.309

Mols, F., Beijers, T., Vreugdenhil, G., & van de Poll-Franse, L. (2014). Chemotherapy-induced peripheral neuropathy and its association with quality of life: A systematic review. Support Care Cancer, 22(8), 2261–2269. https://doi.org/10.1007/s00520-014-2255-7

Morier, A., Lallemant, A., & Romeu, P. (2019). Pratique de la rééducation sensitive des douleurs neuropathiques. Douleurs Évaluation-Diagnostic-Traitement, 20(4), 175–182. https://doi.org/10.1016/j.douler.2019.07.009

Pachman, D. R., Watson, J. C., & Loprinzi, C.L. (2013). Therapeutic Strategies for cancer treatment related peripheral neuropathies. Current Treatment Options in Oncology, 15(4), 567–580. https://doi.org/10.1007/s11864-014-0303-7

Park, S. B., Lin, C. S. Y., Krishnan, A. V., Goldstein, D., Friedlander, M. L., & Kiernan, M. C. (2011). Long-term neuropathy after oxaliplatin treatment: Challenging the dictum of reversibility. Oncologist, 16(5), 708–716. https://doi.org/10.1634/theoncologist.2010-0248

Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain, 155(12), 2461–2470. https://doi.org/10.1016/j.pain.2014.09.020

Société canadienne du cancer [SCC]. (2021, novembre). Statistiques canadiennes sur le cancer 2021 (publication no 0835–2976). https://cdn.cancer.ca/-/media/files/research/cancer-statistics/2021-statistics/2021-pdf-fr final.pdf?rev=d571102f382a487785d7bbd4f54ff92f&hash=

B38D74D77C429E359D4627A7F3B1E589&_ga=2.181759527.1080936648.1641911656-1510802307.1641911656

Spicher, C. (2003). Manuel de rééducation sensitive du corps humain : des troubles de base de la sensibilité cutanée aux complications douloureuses : syndrome loco-régional douloureux complexe, allodynie mécanique, névralgie, lors de lésions neurologiques périphériques et cérébrales (1ere édition). Médecine et Hygiène.

Spicher, C. J., Quintal, I., & Vitaz, M. (2020). Rééducation sensitive des douleurs neuropathiques (4e édition). Sauramps Médical.

Staff, N. P., Grisold, A., Grisold, W., & Windebank, A. J. (2017). Chemotherapy-induced peripheral neuropathy: A current review. Annals of Neurology, 81(6), 772–781. https://doi.org/10.1002/ana.24951

Stout, N. L., Silver, J. K., Alfano, C. M., Ness, K. K., & Gilchrist, L. S. (2019). Long-term survivorship care after cancer treatment: A new emphasis on the role of rehabilitation services. Physical Therapy, 99(1), 10–13. https://doi.org/0.1093/ptj/pzy115

Streckmann, F., Balke, M., Cavaletti, G., Toscanelli, S., Bloch, W., Décard, B. F., Lehmann, H. C., & Faude, O. (2022). Exercise and neuropathy: Systematic review with meta-analysis. Sports Medicine, 52(5), 1043–1065. https://doi.org/10.1007/s40279-021-01596-6

Taïb, S., Durand, J., & Brunet, I. (2020). Neuropathie périphérique induite par l’oxaliplatine. Comment faire barrière? Médecine sciences, 36, 33–37. https://doi.org/10.1051/medsci/2020191

Tanay, M.A., & Armes, J. (2019). Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer. European Journal of Cancer Care, 28(3), e13011. https://doi.org/10.1111/ecc.13011

Tanner, L. R., & Hooke, M. C. (2019). Improving body function and minimizing activity limitations in pediatric leukemia survivors: The lasting impact of the Stoplight Program. Pediatric Blood & Cancer, 66(5), e27596. https://doi.org/10.1002/pbc.27596

Winters-Stone, K. M., Horak, F., Jacobs, P. G., Trubowitz, P., Dieckmann, N. F., Stoyles, S., & Faithfull, S. (2017). Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. Journal of Clinical Oncology, 35(23), 2604–2612. https://doi.org/10.1200/JCO.2016.71.3552

Wolf, S. L., Barton, D. L., Qin, R., Wos, E. J., Sloan, J. A., Liu, H., Aaronson, N. K., Satele, D. V., Mattar, B. I., Green, N. B., & Loprinzi, C. L. (2012). The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer, 20(3), 625–632. https://doi.org/10.1007/s00520-011-1141-9

Yoon, S. Y., & Oh, J. (2018). Neuropathic cancer pain: Prevalence, pathophysiology, and management. Korean Journal of Internal Medecine, 33(6), 1058–1069. https://doi.org/10.3904/kjim.2018.162

Zimmer, P., Trebing, S., Timmers-Trebing U, Schenk, A., Paust, R., Bloch, W. Rudolph, R. Streckmann, F., & Baumann, F. T. (2018). Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: A randomized controlled trial. Support Care Cancer, 26(2), 615–624. https://doi.org/10.1007/s00520-017-3875-5


Refbacks

  • There are currently no refbacks.


Bookmark and Share